Evidence mapPaperPMID 40908401Full record

ReviewReproductive sciences (Thousand Oaks, Calif.)2025

Regulatory Interplay of p53, AMPK, and mTOR in Decidualization: Implications for Reproductive Competence and Cancer Biology.

Hiroshi Kobayashi, Hiroshi Shigetomi, Miki Nishio, Mai Umetani, Shogo Imanaka, Hiratsugu Hashimoto

Abstract readReview
PubMed Publisher
In one paragraph

Review in Reproductive sciences (Thousand Oaks, Calif.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Hiroshi KobayashiDepartment of Gynecology and Reproductive Medicine, Ms.Clinic MayOne, 871-1 Shijo-cho, Kashihara, 634-0813, Japan. hirokoba@naramed-u.ac.jp.ORCID 0000-0002-8124-6269
Hiroshi ShigetomiDepartment of Obstetrics and Gynecology, Nara Medical University, 840 Shijo-cho, Kashihara, 634-8522, Japan.
Miki NishioDepartment of Gynecology and Reproductive Medicine, Ms.Clinic MayOne, 871-1 Shijo-cho, Kashihara, 634-0813, Japan.
Mai UmetaniDepartment of Gynecology and Reproductive Medicine, Ms.Clinic MayOne, 871-1 Shijo-cho, Kashihara, 634-0813, Japan.
Shogo ImanakaDepartment of Gynecology and Reproductive Medicine, Ms.Clinic MayOne, 871-1 Shijo-cho, Kashihara, 634-0813, Japan.
Hiratsugu HashimotoDepartment of Gynecology and Reproductive Medicine, Ms.Clinic MayOne, 871-1 Shijo-cho, Kashihara, 634-0813, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Endometrial dysfunction—particularly impaired decidualization—has emerged as a critical barrier to successful pregnancy establishment. Recent investigations have demonstrated that physiological cellular senescence actively participates in the decidualization process, indicating that the precise induction of moderate senescence appears to be essential for embryo implantation and the maintenance of pregnancy. The molecular pathways governed by p53, AMPK, and mTOR serve as pivotal regulators of cellular differentiation, metabolic homeostasis, autophagy, and senescence, and their coordinated interplay is fundamental to sustaining reproductive competence. In this review, we delineate the distinct regulatory mechanisms of these signaling networks in endometrial versus cancer cells and synthesize their respective roles within the context of reproductive biology. A comprehensive literature search was performed using PubMed and Google Scholar, without temporal limitations. Moderate p53 activity facilitates appropriate decidualization, whereas both hyperactivity and hypoactivity of p53 may lead to implantation failure and preterm birth. To conceptualize this dynamic, we propose a tripartite model of p53 activity (Zones 1–3). AMPK contributes to metabolic homeostasis through the inhibition of mTOR signaling; conversely, hyperactivation of mTOR promotes cellular senescence and disrupts decidualization. While these pathways are constitutively and irreversibly reprogrammed in cancer, they remain reversibly and hormonally regulated in a temporally specific manner in the pregnant endometrium, underscoring the context-dependent versatility of these molecular mediators under physiological versus pathological conditions. These insights highlight the critical role of physiological cellular senescence in reproductive biology and elucidate how its dysregulation may contribute to infertility and pregnancy-related pathologies.

Indexed as

AMP-Activated Protein KinasesDeciduaEmbryo ImplantationReproductionTOR Serine-Threonine KinasesTumor Suppressor Protein p53AnimalsCellular SenescenceEndometriumFemaleHumansPregnancySignal TransductionAMP-Activated Protein KinasesMTOR protein, humanTOR Serine-Threonine KinasesTumor Suppressor Protein p53AMPKCellular senescenceDecidualizationmTORp53

Identifiers

PMID40908401

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.